A legal battle over hundreds of millions in Medicaid funding has taken a dramatic turn, with a federal judge siding – for now – with the White House. The decision allows the administration to temporarily withhold over $259 million from Minnesota, escalating a nationwide crackdown on alleged fraud within the program.
The case stems from a massive fraud scandal in Minnesota, initially uncovered in 2022 and gaining renewed attention in 2025 with a growing number of convictions. The scandal, involving approximately $250 million, quickly became a focal point in the national debate surrounding public benefits and potential abuse.
Judge Eric Tostrud, appointed by former President Trump, determined that Minnesota’s challenge to the funding deferral was premature. He ruled that the Centers for Medicare and Medicaid Services (CMS) was within its rights to demand evidence of legitimate reimbursements before releasing the funds.
This isn’t simply about Minnesota. The administration, spurred by the state’s scandal, launched an anti-fraud task force earlier this year, led by Vice President JD Vance. CMS, under Administrator Mehmet Oz, was directed to proactively withhold Medicaid reimbursements based on *potential* fraud, not just proven cases.
Minnesota’s Attorney General, Keith Ellison, argued that the deferral was a politically motivated “weaponization” of Medicaid, violating both the Administrative Procedures Act and constitutional due process. He claimed the federal government was punishing the state for past issues.
However, Judge Tostrud dismissed this claim, citing a 2019 Supreme Court case. He stated that even if political considerations played a role in the decision, it didn’t automatically render the deferral unlawful. Agency policymaking, he wrote, is inherently influenced by political factors.
The judge’s 42-page order highlighted the “novel” nature of some of Minnesota’s legal arguments, finding insufficient legal basis to support them. This ruling represents a significant win for the administration as it expands its anti-fraud efforts.
Beyond Minnesota, CMS is also considering similar deferrals in California, New York, and Maine. This suggests a wave of litigation is likely to follow, potentially leading to further rulings from federal judges across the country and even escalating the dispute to higher courts.
A state-commissioned review of Minnesota’s Medicaid program revealed vulnerabilities in 14 key service areas, estimating that as much as $1.7 billion in payments could have been “potentially improper” over a four-year period. This report fueled the administration’s broader “war on fraud” and provided justification for the aggressive new approach.
The implications of this case are far-reaching, potentially reshaping how federal oversight of Medicaid is conducted and raising questions about the balance between preventing fraud and ensuring access to vital healthcare services for vulnerable populations.
